News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
853,110 Results
Type
Article (77474)
Company Profile (347)
Press Release (775260)
Multimedia
Podcasts (266)
Webinars (42)
Section
Business (259375)
Career Advice (3857)
Deals (39058)
Drug Delivery (212)
Drug Development (89019)
Employer Resources (210)
FDA (18510)
Job Trends (17143)
News (386772)
Policy (38747)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (2)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (3)
2027 Biotech Beach Standard (5)
2027 Genetown Elite (5)
2027 Genetown Standard (10)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (8)
Academia (3088)
Academic (2)
Accelerated approval (68)
ADA (51)
Adcomms (44)
Allergies (222)
Alliances (56005)
ALS (265)
Alzheimer's disease (2086)
Antibody-drug conjugate (ADC) (664)
Approvals (19005)
Artificial intelligence (989)
ASCO (344)
Autoimmune disease (435)
Automation (75)
Bankruptcy (393)
Belgium (8)
Best Places to Work (12622)
BIO (79)
Biologics (15)
BIOSECURE Act (23)
Biosimilars (283)
BioSpace Insights (252)
Biotechnology (244)
Bispecific (3)
Bladder cancer (229)
Brain cancer (93)
Breast cancer (911)
Cancer (7298)
Cardiovascular disease (635)
Career advice (3331)
Career pathing (61)
CAR-T (421)
CDC (78)
CDMO (184)
Celiac Disease (4)
Cell therapy (1149)
Cervical cancer (61)
Clinical research (77822)
Collaboration (2672)
Commercialization (13)
Company closure (10)
Compensation (1786)
Complete response letters (123)
COVID-19 (3060)
CRISPR (139)
C-suite (1579)
Cystic fibrosis (178)
Data (9766)
Decentralized trials (3)
Denatured (104)
Depression (220)
Dermatology (133)
Diabetes (769)
Diagnostics (7805)
Digital health (78)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (493)
Drug pricing (251)
Drug shortages (39)
Duchenne muscular dystrophy (363)
Earnings (99664)
Editorial (84)
Employer branding (26)
Employer resources (180)
Events (136501)
Executive appointments (1323)
Eye disease (1)
FDA (23204)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (1)
Friedreich's ataxia (25)
Frontotemporal dementia (39)
Funding (2186)
Gene editing (299)
Generative AI (94)
Gene therapy (918)
GLP-1 (1344)
Government (5562)
Grass and pollen (8)
Guidances (436)
Healthcare (21357)
Hematology (197)
HIV (114)
Huntington's disease (77)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (134)
Immunology and inflammation (405)
Immuno-oncology (140)
Indications (251)
Infectious disease (3488)
Inflammatory bowel disease (253)
Inflation Reduction Act (17)
Influenza (159)
Intellectual property (362)
Interviews (751)
IPO (17821)
IRA (61)
Job creations (4824)
Job search strategy (2667)
JPM (73)
Kidney cancer (27)
Labor market (137)
Layoffs (712)
Leadership (61)
Legal (9691)
Licensing (31)
Liver cancer (115)
Longevity (45)
Lung cancer (1004)
Lymphoma (522)
Machine learning (75)
Management (70)
Manufacturing (1474)
Marketing (13)
MASH (241)
Medical affairs (3)
Medical device (15377)
Medtech (15646)
Mergers & acquisitions (22717)
Metabolic disorders (1984)
mRNA (310)
Multiple sclerosis (228)
Multispecific (1)
NASH (24)
Netherlands (7)
Neurodegenerative disease (583)
Neuropsychiatric disorders (147)
Neuroscience (4086)
Neurotech (1)
NextGen: Class of 2026 (7601)
Non-profit (5162)
Now hiring (93)
Obesity (939)
Opinion (397)
Ovarian cancer (263)
Pain (318)
Pancreatic cancer (405)
Parkinson's disease (457)
Partnered (45)
Patents (757)
Patient advocacy (1)
Patient recruitment (953)
Patient selection (7)
Peanut (74)
People (67304)
Peptides (8)
Pharmaceutical (69)
Pharmacy benefit managers (40)
Phase 1 (24125)
Phase 2 (33854)
Phase 3 (25650)
Pipeline (12392)
Policy (417)
Postmarket research (3180)
Preclinical (10540)
Press Release (72)
Prostate cancer (377)
Psychedelics (92)
Radiopharmaceuticals (416)
Rare diseases (1485)
Real estate (7151)
Recruiting (83)
Regenerative medicine (2)
Regulatory (30606)
Reports (91)
Research institute (2795)
Resumes & cover letters (611)
Rett syndrome (52)
RNA editing (33)
RSV (102)
Schizophrenia (212)
Series A (380)
Series B (269)
Service/supplier (15)
Sickle cell disease (138)
Special edition (36)
Spinal muscular atrophy (196)
Sponsored (59)
Startups (4218)
State (2)
Stomach cancer (22)
Supply chain (159)
Tariffs (105)
The Weekly (159)
Vaccines (1386)
Venture capital (164)
Weight loss (633)
Wet AMD (1)
Women's health (170)
Worklife (27)
Date
Today (123)
Last 7 days (509)
Last 30 days (2615)
Last 365 days (33106)
2026 (24124)
2025 (32433)
2024 (37490)
2023 (42549)
2022 (53911)
2021 (58699)
2020 (57643)
2019 (51288)
2018 (39076)
2017 (36795)
2016 (37500)
2015 (44137)
2014 (39297)
2013 (35161)
2012 (35627)
2011 (35626)
2010 (34005)
Location
Africa (1207)
Alabama (113)
Alaska (7)
Arizona (442)
Arkansas (16)
Asia (50984)
Australia (8676)
California (15921)
Canada (4424)
China (1855)
Colorado (682)
Connecticut (710)
Delaware (493)
Europe (115965)
Florida (2438)
Georgia (522)
Hawaii (5)
Idaho (70)
Illinois (1369)
India (131)
Indiana (725)
Iowa (31)
Japan (709)
Kansas (153)
Kentucky (65)
Louisiana (67)
Maine (95)
Maryland (1906)
Massachusetts (11554)
Michigan (445)
Minnesota (876)
Mississippi (7)
Missouri (180)
Montana (37)
Nebraska (31)
Nevada (178)
New Hampshire (92)
New Jersey (4195)
New Mexico (38)
New York (4172)
North Carolina (2099)
North Dakota (12)
Northern California (8070)
Ohio (510)
Oklahoma (31)
Oregon (49)
Pennsylvania (3053)
Puerto Rico (34)
Rhode Island (58)
South America (1590)
South Carolina (97)
South Dakota (2)
Southern California (6337)
Tennessee (265)
Texas (2617)
United States (56625)
Utah (486)
Vermont (2)
Virginia (405)
Washington D.C. (88)
Washington State (1288)
West Virginia (4)
Wisconsin (180)
Wyoming (4)
853,110 Results for "boehringer ingelheim pharma gmbh and co kg".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pipeline
Boehringer Ingelheim suspends early study for pill candidate after ‘safety event’
Not much is known about Boehringer Ingelheim’s drug candidate, dubbed BI 3031185, though the asset has completed at least two other Phase 1 studies this year.
August 24, 2026
·
1 min read
·
Tristan Manalac
Cancer
Boehringer Ingelheim bets up to $1B in AI-centered solid tumor collab with Envisagenics
Envisagenics’ platform makes use of AI to screen and detect cancer-specific RNA alterations, which Boehringer Ingelheim wants to target through various precision treatment modalities, including multi-specific antibodies, antibody-drug conjugates and T cell engagers.
September 22, 2026
·
2 min read
·
Tristan Manalac
Press Releases
BioMed X and Boehringer Ingelheim Expand XSeed Labs to Advance Next-Generation Eye Therapies
· New research team expands capabilities at Boehringer’s U.S. R&D site in Ridgefield, Connecticut.
July 9, 2026
·
1 min read
Obesity
ADA: Boehringer leans on fat mass benefits as obesity bet delivers ‘less competitive’ weight reduction
While survodutide’s 16.6% overall weight loss was underwhelming, Boehringer Ingelheim and Zealand Pharma’s drug achieved “impressive” fat loss, according to BMO Capital Markets.
June 8, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Boehringer Ingelheim Spotlights Next Generation of Veterinary Researchers
August 10, 2026
·
5 min read
Press Releases
Owkin to License K Pro AI Scientist and Multimodal Oncology and Immunology Data to Boehringer Ingelheim
September 2, 2026
·
1 min read
Press Releases
Boehringer Ingelheim launches PED Essentials, an online learning resource that gives patients a stronger voice
September 17, 2026
·
4 min read
Manufacturing
Lilly and Boehringer roll back billions in German investments over health budget cuts
With Germany moving to curb healthcare spending, Eli Lilly and Boehringer Ingelheim have rethought plans to invest in facilities, including a manufacturing plant for GLP-1 drugs.
June 4, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Boehringer Ingelheim expands equine health pipeline with acquisition of Evax AG
August 11, 2026
·
3 min read
Press Releases
Boehringer Ingelheim Celebrates Grand Opening of New U.S. Animal Health Headquarters in Johns Creek, Georgia
August 31, 2026
·
3 min read
1 of 85,311
Next